Verteporfin Photodynamic Therapy Combined With Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration

This publication has 33 references indexed in Scilit:

• Comparison of Visual Acuity in Macular Degeneration Patients Measured with Snellen and Early Treatment Diabetic Retinopathy Study Charts
  Ophthalmology, 2008
• COMBINED PHOTODYNAMIC THERAPY WITH VERTEPORFIN AND INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
  Retina, 2006
• Ranibizumab for Neovascular Age-Related Macular Degeneration
  New England Journal of Medicine, 2006
• Verteporfin and Intravitreal Triamcinolone Acetonide Combination Therapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration
  American Journal of Ophthalmology, 2006
• Verteporfin Therapy Combined with Intravitreal Triamcinolone in All Types of Choroidal Neovascularization due to Age-Related Macular Degeneration
  Ophthalmology, 2006
• Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect
  Current Medical Research and Opinion, 2005
• Photodynamic therapy with verteporfin in ocular histoplasmosis: Uncontrolled, open-label 2-year study
  Ophthalmology, 2004
• Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials—TAP and VIP report no. 3
  American Journal of Ophthalmology, 2004
• VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
  Retina, 2004
• Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization
  Ophthalmology, 2003